Another, slightly extended construct containing CCP1–5 and 18–20 domains effectively inhibited complement activation in vivo and reduced abnormal glomerular C3 deposition in a FH-deficient mouse model of C3 glomerulopathy (194). Here, C3 is linked to complement 3 glomerulopathy.